Osteoporosis is a growing health concern, characterised by deterioration of bone and increased fracture incidence. Anabolic treatments for reversing bone loss are presently limited. A bone anabolic response was recently reported following deletion of hypothalamic neuropeptide Y2 receptors in mice. In contrast, no discernable bone phenotype was observed in Y4 receptor knockout (Y4-/-) mice, revealing specificity between the Y receptors in their control of bone formation. Studies in this thesis revealed a second anabolic response in the absence of another Y receptor subtype; the Y1 receptor. The potential interaction between the Y1 and Y2- anabolic pathways with each other and with Y4 was investigated through the generation of mouse models lacking multiple Y receptor subtypes. Interestingly, no synergistic elevation in bone volume was observed in Y1-/-Y2-/- double knockout mice, indicative of shared mechanisms of action. In contrast, the synergistic elevation in bone volume of male Y2-/- Y4-/- mice was likely due to additive effects of leptin signalling. Consequentially, potential interaction between Y receptors and leptin was investigated by crossing the Y receptor knockouts onto the leptin deficient ob/ob background, revealing differential responses of the Y receptor pathways to leptin deficiency, with the anabolic response of the Y2-/- model retained in Y2-/-/ob mice but abolished in Y1-/-/ob mice compared to Y1-/-. Differential responses of these two pathways were also revealed following gonadectomy of Y1-/- and Y2-/- mice. Importantly, these studies also demonstrated the ability of the central Y2- anabolic pathway to halt gonadectomy-induced bone loss. Interestingly, cultured stromal cells from germline Y2-/- mice exhibited an enhanced ability to undergo mineralisation and adipocyte differentiation, associated with a greater number of mesenchymal progenitor cells present within the bone of Y2-/- mice, suggesting a potential mechanism for the greater mineralisation of the Y2-/- model in vitro and in vivo. Y1 receptor expression was also detected in stromal cells from wild type mice, but was nearly abolished in Y2-/- mice. Together these findings demonstrate an important therapeutic potential for these pathways in the treatment of osteoporosis and indicate that modulation of Y receptor signalling within the bone microenvironment may alter proportions of mesenchymal progenitor populations with effects on bone formation.
| Identifer | oai:union.ndltd.org:ADTP/187170 |
| Date | January 2006 |
| Creators | Alison, Susan Jean, School of Medicine, UNSW |
| Publisher | Awarded by:University of New South Wales. School of Medicine |
| Source Sets | Australiasian Digital Theses Program |
| Language | English |
| Detected Language | English |
| Rights | Copyright Susan Jean Alison, http://unsworks.unsw.edu.au/copyright |
Page generated in 0.0026 seconds